The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel is set to review data and offer ...
Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and ...
October 30, 2015 โ Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable ...
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for ...
October 23, 2015 โ Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found ...
October 16, 2015 โ Results from a clinical trial showed that Abbott's Absorb everolimus-eluting bioresorbable vascular ...
October 15, 2015 โ Two new advances in stent technology announced in recent days further reinforce the effectiveness of ...
September 4, 2015 โ A drug-eluting coronary stent made of absorbable material performed similarly to gold-standard metal ...
September 1, 2015 โ A bioresorbable drug-eluting coronary stent showed similar efficacy and safety results compared to a ...
September 1, 2015 โ Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of ...